Science Explorer Back to mapMap
Discussion
Researcher · VIB-UGent Center for Inflammation Research · Belgium

Martin Guilliams

Martin Guilliams publishes mostly in Immunology, Molecular Biology and Epidemiology, on topics such as Immune cells in cancer, Immunotherapy and Immune Responses and Immune Cell Function and Interaction.

ORCID 0000-0003-3525-7570 OpenAlex
World rank
#20,016
of 7,710,434 ranked researchers
Rank in Belgium
#52
of 67,186
Works
166
Citations
31k
Citations per work
186.9
h-index
65
i10-index 107Top 2% in Immunology
Martin Guilliams

What does Martin Guilliams research?

Martin Guilliams's work is mostly in Immunology and Microbiology (47%), Biochemistry, Genetics and Molecular Biology (12%), Medicine (11%).

Life Sciences: 104 works · 62.6% of their workImmunology and Microbiology: 79 works · 47.4% of their workImmunology: 79 works · 47.4% of their workBiochemistry, Genetics and Molecular Biology: 20 works · 11.8% of their workMolecular Biology: 20 works · 11.8% of their workNeuroscience: 6 works · 3.4% of their workNeurology: 6 works · 3.4% of their workEverything else: 44 works · 26.5% of their workHealth Sciences: 18 works · 10.9% of their workMedicine: 18 works · 10.9% of their workEpidemiology: 8 works · 4.7% of their workPulmonary and Respiratory Medicine: 6 works · 3.4% of their workPhysiology: 5 works · 2.8% of their workTHEIR WORKMartin Guilliams166works
Life Sciences63%Health Sciences11%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology7947.4%
    2. Biochemistry, Genetics and Molecular Biology2011.8%
    3. Neuroscience63.4%
  2. Everything else4426.5%
    1. Medicine1810.9%
  1. 1Immunology47% of their works
  2. 2Molecular Biology12% of their works
  3. 3Epidemiology5% of their works
  4. 4Pulmonary and Respiratory Medicine3% of their works
  5. 5Neurology3% of their works
  6. 6Physiology3% of their works

Research topics

Which keywords describe Martin Guilliams's research?

The keywords of their largest research topics: Immunity, Inflammation, Activation, Innate Immunity, Macrophage, Cancer Immunotherapy, Antigen Presentation and Dendritic Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Immunity992 topics
  2. Inflammation762 topics
  3. Activation571 topic
  4. Innate Immunity572 topics
  5. Macrophage571 topic
  6. Cancer Immunotherapy562 topics
  7. Antigen Presentation421 topic
  8. Dendritic Cells421 topic
  9. NK Cell Recognition331 topic
  10. Natural Killer Cells331 topic
  11. Foxp3321 topic
  12. TGF-ß321 topic
  13. Pattern Recognition Receptors191 topic
  14. Toll-like Receptors191 topic
  15. Single-Cell171 topic
  16. Transcriptomics171 topic
  17. Microglia151 topic
  18. Neuroinflammation151 topic
  19. CD47141 topic
  20. apoptotic cells141 topic

Where does Martin Guilliams work?

Martin Guilliams's main affiliation in the publication record is VIB-UGent Center for Inflammation Research, Belgium.

How many publications and citations does Martin Guilliams have?

OpenAlex counts 166 works and 31,033 citations for Martin Guilliams, an h-index of 65, ranking #20,016 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Martin Guilliams. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.